Medium/Large Size Posterior Uveal Melanoma Active Not Recruiting Phase 2 Trials for Rasdegafusp alfa (DB15185)

IndicationStatusPhase
DBCOND0047816 (Medium/Large Size Posterior Uveal Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02129075CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV MelanomaTreatment